Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
PMCID: PMC8753508
Evaluate evidence and feasibility for using GLP-1As for an eating disorder
Get emergency care right away if you experience: Severe skin reactions: A sudden rash, blisters, or peeling Sudden vision problems: Blurred vision, loss of vision, double vision, eye pain, redness Neurological emergencies: A new or worsening seizure, severe coordination problems, confusion, or an inability to respond to your surroundings (coma) Cardiovascular symptoms: Chest pain, a pounding or irregular heartbeat, or severe shortness of breath Contact your healthcare provider promptly if you experience: Kidney problems: Intense lower back or side pain, blood in your urine, painful urination, or unusually frequent urination Cognitive changes: Persistent difficulty concentrating, speech problems, or ongoing memory issues
GLP-1 medications are not officially FDA-approved for the treatment of PCOS, but theyre sometimes used off-label for PCOS, because of their effect on insulin resistance
Independent testing helps ensure the supplement contains what the label states, and reduces the risk of contaminants, which improves overall safety and quality, Brown says
FDA-Approved Uses for Tirzepatide Tirzepatide is currently marketed under two brand names with distinct FDA-approved indications: Mounjaro received FDA approval in May 2022 for improving glycemic control in adults with type 2 diabetes
